VetBioLogix was founded with a singular purpose: to empower veterinarians with innovative, science-backed solutions that improve outcomes for equine athletes. We are proud to offer U.S.-manufactured products, shipped nationwide, and competitively priced to ensure accessibility for clinicians.
Every product undergoes rigorous third-party testing, with certificates of analysis available to guarantee quality and transparency. Our advanced peptide synthesis methods, including solid-phase techniques and modern post-synthesis purification, ensure exceptional quality and efficacy.
By partnering with VetBioLogix, you’re not just choosing a product—you’re choosing a trusted ally in your mission to deliver the best care for your patients.
Built by the clinical community, with a commitment to transparency and quality.
Cutting-edge peptide therapeutics that give you an edge in equine care.
We work hand-in-hand with veterinarians to advance the standard of care.
Dr. Charley McColough serves as the Chief Veterinary Officer of VetBioLogix, bringing together the experience of an equine performance clinician with the vision of optimizing equine health and recovery.
With a foundation in biomedical research at Weill Cornell Medical College and a veterinary medical degree from the prestigious Royal Veterinary College of London, Dr. McColough has fostered a keen interest in advancing animal health through clinical research.
Dr. McColough is currently leading clinical studies to further document the safety and efficacy of peptide-based therapeutics in equine patients.
As the founder of Whetstone Equine, Dr. McColough’s passion for exceptional care is uniquely aligned with our mission to revolutionize equine performance through innovative science-backed solutions.
The American Peptide Association is an industry organization dedicated to promoting integrity, accountability, and responsible growth within the peptide sector. Its mission centers on establishing higher standards across sourcing, manufacturing, labeling, and distribution practices. By encouraging ethical conduct and structured operational guidelines, the Association seeks to create a more transparent and professionally aligned peptide marketplace.
Through advocacy and industry collaboration, the organization works to support businesses that prioritize compliance, quality control, and accurate product representation. It emphasizes responsible communication, appropriate research-use positioning, and adherence to regulatory frameworks relevant to peptide distribution. In doing so, the Association aims to help elevate trust and credibility across the broader scientific and research community.
In addition to setting standards, the American Peptide Association serves as a unifying voice for companies operating within the peptide space. By fostering education, structured best practices, and professional accountability, it contributes to the long-term sustainability and reputation of the industry. Its focus remains on strengthening operational discipline while encouraging innovation within a compliant and research-focused environment.
